220 related articles for article (PubMed ID: 30983168)
1. [Is apheresis still a useful tool in the treatment of nephrological diseases?].
Santoro A
G Ital Nefrol; 2019 Apr; 36(2):. PubMed ID: 30983168
[TBL] [Abstract][Full Text] [Related]
2. New Options of Apheresis in Renal Diseases: How and When?
Korsak J; Wańkowicz Z
Blood Purif; 2016; 41(1-3):1-10. PubMed ID: 26960209
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic apheresis in kidney diseases: an updated review.
Chen YY; Sun X; Huang W; He FF; Zhang C
Ren Fail; 2022 Dec; 44(1):842-857. PubMed ID: 35723077
[TBL] [Abstract][Full Text] [Related]
4. Application of LDL-apheresis and immunoadsorption in kidney diseases.
Sułowicz W; Stompór T
Rocz Akad Med Bialymst; 2004; 49():127-34. PubMed ID: 15631328
[TBL] [Abstract][Full Text] [Related]
5. Pediatric therapeutic apheresis: rationale and indications for plasmapheresis, cytapheresis, extracorporeal photopheresis, and LDL apheresis.
Kim YA; Sloan SR
Pediatr Clin North Am; 2013 Dec; 60(6):1569-80. PubMed ID: 24237988
[TBL] [Abstract][Full Text] [Related]
6. [How to implement a complete apheresis program within a hemodialysis unit].
Maurizi-Balzan J; Jouve T; Naciri-Bennani H; Noble J; Tanoukhi K; Motte L; Malvezzi P; Rostaing L
Nephrol Ther; 2019 Nov; 15(6):439-447. PubMed ID: 31585841
[TBL] [Abstract][Full Text] [Related]
7. Divide et Vinces, Therapeutic Apheresis in Nephrological Clinical Practice.
Mantilla J; Peña D; Molano-Triviño A; Zúñiga E; Castellanos-De La Hoz JC
Blood Purif; 2024; 53(3):162-169. PubMed ID: 38113864
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
[TBL] [Abstract][Full Text] [Related]
9. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.
Schwartz J; Padmanabhan A; Aqui N; Balogun RA; Connelly-Smith L; Delaney M; Dunbar NM; Witt V; Wu Y; Shaz BH
J Clin Apher; 2016 Jun; 31(3):149-62. PubMed ID: 27322218
[TBL] [Abstract][Full Text] [Related]
10. Apheresis for Kidney Disease.
Furuichi K; Wada T
Contrib Nephrol; 2018; 196():188-193. PubMed ID: 30041226
[TBL] [Abstract][Full Text] [Related]
11. Advances in apheresis therapy for glomerular diseases.
Yokoyama H; Wada T; Zhang W; Yamaya H; Asaka M
Clin Exp Nephrol; 2007 Jun; 11(2):122-127. PubMed ID: 17593511
[TBL] [Abstract][Full Text] [Related]
12. Physiological role of plasma and its components and the clinical implications of different methods of apheresis: A narrative review.
Ahmadpoor P; Aglae C; Cariou S; Pambrun E; Renaud S; Garo F; Darmon R; Schultz C; Prelipcean C; Reboul P; Moranne O
Ther Apher Dial; 2021 Jun; 25(3):262-272. PubMed ID: 32710797
[TBL] [Abstract][Full Text] [Related]
13. Conventional apheresis therapies: a review.
Ward DM
J Clin Apher; 2011; 26(5):230-8. PubMed ID: 21882233
[TBL] [Abstract][Full Text] [Related]
14. The ABC of apheresis.
Dierickx D; Macken E
Acta Clin Belg; 2015 Apr; 70(2):95-9. PubMed ID: 25366579
[TBL] [Abstract][Full Text] [Related]
15. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
16. Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
Siciliano G; Moriconi L; Gianni G; Richieri E; Vignocchi MG; Rossi B
Acta Neurol Scand; 1994 Feb; 89(2):117-22. PubMed ID: 8191874
[TBL] [Abstract][Full Text] [Related]
17. The selective therapeutic apheresis procedures.
Sanchez AP; Cunard R; Ward DM
J Clin Apher; 2013 Feb; 28(1):20-9. PubMed ID: 23420592
[TBL] [Abstract][Full Text] [Related]
18. Quo vadis haemapheresis. Current developments in haemapheresis.
Borberg H
Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
[TBL] [Abstract][Full Text] [Related]
19. Practical considerations for planning a therapeutic apheresis procedure.
Shelat SG
Am J Med; 2010 Sep; 123(9):777-84. PubMed ID: 20541168
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis.
Ewald N; Kloer HU
Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):31-5. PubMed ID: 22528130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
